Following surgery and clinical improvement, there was no longer a correlation of these questionnaires with any serum marker, which led the authors to conclude that the improvement in low-degree inflammation associated with obesity and the reduction in leptin had little or no importance in the clinical improvement associated with the weight loss. The gene discussed is LEP; the disease is obesity disorder.